On CK2 regulation of chronic lymphocytic leukemia cell viability
暂无分享,去创建一个
[1] J. Gribben,et al. Update on therapy of chronic lymphocytic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Richard Sherry,et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. , 2011, Blood.
[3] J. Barata,et al. Targeting CK2 overexpression and hyperactivation as a novel therapeutic tool in chronic lymphocytic leukemia. , 2010, Blood.
[4] U. Jaeger,et al. Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia. , 2010, Blood.
[5] J. Barata,et al. Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and γ-secretase inhibitors , 2010, Haematologica.
[6] M. Keating,et al. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. , 2009, Blood.
[7] K. Stamatopoulos,et al. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation , 2008, Journal of internal medicine.
[8] J. Barata,et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. , 2008, The Journal of clinical investigation.
[9] C. Rehder,et al. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia , 2007, American journal of hematology.
[10] J. Cheong,et al. Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia , 2007, Clinical Cancer Research.
[11] N. Varin‐Blank,et al. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression. , 2006, Cancer research.
[12] G. Unger,et al. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model. , 2004, Molecular cancer research : MCR.
[13] P. Chiusolo,et al. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. , 2004, Blood.
[14] J. Plate. PI3-Kinase Regulates Survival of Chronic Lymphocytic Leukemia B-Cells by Preventing Caspase 8 Activation , 2004, Leukemia & lymphoma.
[15] F. Martín-Saavedra,et al. A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells , 2004, Leukemia.
[16] C. Peschel,et al. Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. , 2002, Blood.
[17] J. Barata. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival. , 2011, Advances in enzyme regulation.
[18] H. Döhner,et al. From pathogenesis to treatment of chronic lymphocytic leukaemia , 2010, Nature Reviews Cancer.
[19] H. Döhner,et al. Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids , 2007, Leukemia.
[20] J. Cheong,et al. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.